Search results

Interferon beta-1b 250microgram/ml for solution for injection (Betaferon)

Multiple sclerosis

natalizumab 300mg concentrate for solution for infusion (Tysabri)

Multiple sclerosis

peginterferon beta 1a (Plegridy)

In adult patients for the treatment of relapsing remitting multiple sclerosis.

glatiramer acetate (Copaxone)

treatment of relapsing forms of multiple sclerosis (MS).

daclizumab (Zinbryta)

In adult patients for the treatment of relapsing forms of multiple sclerosis.

ozanimod (Zeposia)

For adult patients with relapsing remitting multiple sclerosis.

Avonex® liquid (Interferon beta 1a)

Ambulatory patients with relapsing multiple sclerosis (MS)

teriflunomide (Aubagio)

Treatment of adults with relapsing remitting multiple sclerosis (MS).

diroximel fumarate (Vumerity)

For treatment of adult patients with relapsing remitting multiple sclerosis (RRMS)

cladribine (Mavenclad)

Treatment of adult patients with relapsing forms of multiple sclerosis (RMS) with active disease as defined by clinical or imaging features.

ocrelizumab (Ocrevus)

Treatment of adult patients with relapsing forms of multiple sclerosis (RMS) with active disease defined by clinical or imaging features.

fampridine (Fampyra)

For the improvement of walking in adult patients with multiple sclerosis (MS) with walking disability (EDSS [expanded disability status scale] 4 to 7).

ponesimod (Ponvory)

For the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) with active disease defined by clinical or imaging features.

ublituximab (Briumvi)

For the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) with active disease defined by clinical or imaging features.

fingolimod (Gilenya)

As a single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following adult patient groups: